Details
 

May 29 - June 1, 2010

Heart Failure 2010

Berlin, Germany

Advances in CRT and LV Reverse Remodeling in Heart Failure  
CME
   (0.5 credits   See website for details)

Faculty: Gregg Fonarow, MD, Michael R. Gold, MD, PhD, and Helmut Klein, MD

Learn more about the use of CRT devices in early-stage HF and its effects on prevention of disease progression. Learning objectives are:

  • Discuss the CRT LV reverse remodeling results from CARE-HF, REVERSE, and MADIT-CRT 
  • Describe the role these results will play in clinical practice

View Program On-line.

Program was released on December 22, 2009 and is valid for credit through December 22, 2010.
A continuing education activity sponsored by Medscape® on theheart.org.
Supported by an independent educational grant from Medtronic, Inc.

Survival with ICD in Heart Failure: "Real-World" Experience on Par with Trials 
CME
   (0.25 credits   See website for details)

Heartwire CME Authors: Steve Stiles and Désirée Lie, MD, MSEd

This is a retrospective examination of data from two cardiac registries, the OPTIMIZE-HF and the Get With the Guidelines-Heart Failure registries, which were later merged, to compare mortality outcomes of ICD vs no ICD in older patients admitted for heart failure.

View Program On-Line.

Program was released on December 23, 2009 and is valid for credit through December 23, 2010.
A continuing education activity developed and funded by Medscape®.

Risk Stratification in Hypertrophic Cardiomyopathy: ICD Therapy  
CME
   (0.5 credits   See website for details)

Faculty: Eric N. Prystowsky, MD and Mark Estes, MD

Learning objectives are:

  • Describe the data supporting the rationale for the targeted use of ICDs in cardiac arrhythmia patients
  • Implement the current guidelines for the management of patients with cardiac arrhythmias
  • Apply risk stratification strategies to determine appropriate use of ICDs in arrhythmia management

View Program On-line.

Program was released on December 17, 2009 and is valid for credit through December 17, 2010.
A continuing education activity on theheart.org.
Supported by an independent educational grant from Medtronic, Inc.

DES Comparisons: Insights from Late-term Follow-up  
CME
   (0.5 credits   See website for details)

Faculty: Spencer B. King, III, MD and David O. Williams, MD

Learning objectives are:

  • Apply clinical trial data on the safety and efficacy of DES to the management of patients undergoing percutaneous coronary intervention
  • Compare and contrast short- and long-term outcomes from various Drug Eluting Stent (DES) studies

View Program On-line.

Program was released on December 22, 2009 and is valid for credit through December 22, 2010.
A continuing education activity sponsored by Medscape® on theheart.org.
Supported by an independent educational grant from Medtronic, Daiichi Sankyo, Inc., and Eli Lilly and Company.

 

Dual Antiplatelet Therapy: Dueling Options in Real-World Practice  
CME
   (0.25 credits   See website for details)

Faculty: Spencer B. King, III, MD, Deepak L. Bhatt, MD, and Ph. Gabriel Steg, MD

This program is intended for physicians involved in the care of patients undergoing PCI for acute coronary syndrome.
Learning objectives include:

  • Review the role of dual antiplatelet therapy in patients undergoing PCI
  • Apply recent data to the optimal management of antiplatelet therapy in patients undergoing revascularization

View Program On-line.

Program was released on September 30, 2009 and is valid for credit through September 30, 2010.
A continuing education activity sponsored by Medscape® on theheart.org.
Supported by an independent educational grant from Medtronic, Daiichi Sankyo, Inc., and Eli Lilly and Company.

More Info


| Add to my Outlook® Calendar